Biotechnology Daily
more-
Guardant Health takes its cancer blood tests to China through clinical trial partnership
After launching its first liquid biopsy service in Europe earlier this year, the cancer test…
Market Watch
more-
Galaxy Digital shares jump despite widening losses in the second quarter
Crypto investment firm Galaxy Digital GLXY, +8.41%, which was founded by billionaire Michael Novogratz, saw…
Bio Business News
more
Doubling down on mRNA, BeiGene taps rising Hong Kong star to create targeted therapies
BeiGene is getting deeper into mRNA drug discovery. Having teamed…
Pfizer acquisition target ResApp reels in FDA nod for iPhone app to detect sleep apnea
While ResApp Health waits for a final decision on Pfizer’s…
BeiGene’s R&D chief knows PD-1 is crowded. But TIGIT, combos and a Novartis partnership put asset in play
With an FDA target decision date set for next week,…
World News
more
Stocks close with a round of records, Dow clinches 35,000
U.S. stocks swept to another round of records Monday as…
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Guardant Health takes its cancer blood tests to China through clinical trial partnership
Nordic Nanovector pulls the plug on troubled Paradigm trial, moves for restructuring
Labcorp launches monkeypox PCR tests through CDC initiative
OBI Pharma culls early cancer asset as it focuses on later-stage bets
Doubling down on mRNA, BeiGene taps rising Hong Kong star to create targeted therapies
Pfizer acquisition target ResApp reels in FDA nod for iPhone app to detect sleep apnea
BeiGene’s R&D chief knows PD-1 is crowded. But TIGIT, combos and a Novartis partnership put asset in play
Joining the resistance: Boehringer rounds up allies to build €40M anti-superbug startup
Galaxy Digital shares jump despite widening losses in the second quarter
Bed Bath & Beyond shares soar 45% as WallStreetBets crowd chase the former meme stock